Ravi Misra
Stock Analyst at Truist Financial
(0.50)
# 3,981
Out of 4,356 analysts
42
Total ratings
35%
Success rate
-10.7%
Average return
Main Sectors:
Stocks Rated by Ravi Misra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORGO Organogenesis Holdings | Initiated Coverage: Hold | $3 | $2.57 | +16.73% | 1 | May 28, 2026 | |
| TFX Teleflex | Reiterated: Hold | $143 | $128.64 | +11.16% | 1 | May 11, 2026 | |
| IART Integra LifeSciences Holdings | Maintained: Hold | $14 | $16.04 | -12.72% | 1 | May 6, 2026 | |
| KIDS OrthoPediatrics | Reiterated: Hold | $17 | $17.17 | -0.99% | 1 | May 1, 2026 | |
| ALGN Align Technology | Rated: Hold | n/a | $174.95 | n/a | 4 | Dec 13, 2021 | |
| DXCM DexCom | Rated: Hold | n/a | $73.74 | n/a | 2 | Dec 13, 2021 | |
| PODD Insulet | Rated: Hold | n/a | $144.94 | n/a | 3 | Dec 13, 2021 | |
| MASI Masimo | Rated: Hold | n/a | $178.45 | n/a | 4 | Dec 13, 2021 | |
| TNDM Tandem Diabetes Care | Rated: Hold | n/a | $17.20 | n/a | 2 | Dec 13, 2021 | |
| AVNS Avanos Medical | Rated: Hold | n/a | $24.80 | n/a | 2 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $103.35 | n/a | 2 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.61 | n/a | 7 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $41.36 | n/a | 5 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.92 | n/a | 2 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.83 | n/a | 4 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $283 | $424.64 | n/a | 1 | Apr 19, 2017 |
Organogenesis Holdings
May 28, 2026
Initiated Coverage: Hold
Price Target: $3
Current: $2.57
Upside: +16.73%
Teleflex
May 11, 2026
Reiterated: Hold
Price Target: $143
Current: $128.64
Upside: +11.16%
Integra LifeSciences Holdings
May 6, 2026
Maintained: Hold
Price Target: $14
Current: $16.04
Upside: -12.72%
OrthoPediatrics
May 1, 2026
Reiterated: Hold
Price Target: $17
Current: $17.17
Upside: -0.99%
Align Technology
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $174.95
Upside: n/a
DexCom
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $73.74
Upside: n/a
Insulet
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $144.94
Upside: n/a
Masimo
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $178.45
Upside: n/a
Tandem Diabetes Care
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $17.20
Upside: n/a
Avanos Medical
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $24.80
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $103.35
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $7.61
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $41.36
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $1.92
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $9.83
Upside: n/a
Apr 19, 2017
Reiterated: Buy
Price Target: $283
Current: $424.64
Upside: n/a